A stratification system for evaluating and selecting therapies in patients with relapsed or primary refractory acute myelogenous leukemia

Blood. 1996 Jul 15;88(2):756.
No abstract available

Publication types

  • Letter

MeSH terms

  • Acute Disease
  • Adult
  • Aged
  • Bayes Theorem
  • Clinical Trials, Phase II as Topic / methods
  • Disease-Free Survival
  • Drug Resistance, Neoplasm
  • Humans
  • Leukemia, Myeloid / drug therapy*
  • Leukemia, Myeloid / mortality
  • Middle Aged
  • Patient Selection*
  • Prognosis
  • Prospective Studies
  • Remission Induction
  • Salvage Therapy*
  • Treatment Outcome